However, in Hepa1-6 tumors, 32-134D inhibited the expression of the checkpoint ligands B7H4 and PDL1, and the checkpoint receptor TIM3, which are all associated with mortality in HCC (53). This evidence concerns the gene VTCN1 and hepatocellular carcinoma.